Browse > Article
http://dx.doi.org/10.4333/KPS.2005.35.2.089

Preparation and Characterization of Lysozyme Nanoparticles using Solution Enhanced Dispersion by Supercritical Fluid (SEDS) Process  

Kim, Dong-Hyun (College of Pharmacy, Chungnam National University)
Park, Hee-Jun (College of Pharmacy, Chungnam National University)
Kang, Sun-Ho (College of Pharmacy, Chungnam National University)
Jun, Seoung-Wook (College of Pharmacy, Chungnam National University)
Kim, Min-Soo (College of Pharmacy, Chungnam National University)
Lee, Si-Beum (College of Pharmacy, Chungnam National University)
Park, Jeong-Sook (College of Pharmacy, Chungnam National University)
Hwang, Sung-Joo (College of Pharmacy, Chungnam National University)
Publication Information
Journal of Pharmaceutical Investigation / v.35, no.2, 2005 , pp. 89-94 More about this Journal
Abstract
The micron or nano-sized lysozyme as a model protein drug was prepared using solution enhanced dispersion by supercritical fluid (SEDS) process at various conditions (e.g., solvent, temperature and pressure) to investigate the feasibility of pulmonary protein drug delivery. The lysozyme particles prepared were characterized by laser diffraction particle size analyzer, scanning electron microscopy (SEM) and powder X-ray diffractometry (PXRD). The biological activity of lysozyme particles after/before SEDS process was also examined. Lysozyme was precipitated as spherical particles. The precipitated particles consisted of 100 - 200 nm particles. Particle size showed the precipitates to be agglomerates with primary particles of size $1\;-\;5 \;{\mu}m$. The biological activity varied between 38 and 98% depending on the experimental conditions. There was no significant difference between untreated lysozyme and lysozyme after SEDS process in PXRD analysis. Therefore, the SEDS process could be a novel method to prepare micron or nano-sized lysozyme particles, with minimal loss of biological activity, for the pulmonary delivery of protein drug.
Keywords
Supercritical fluid; Solution enhanced dispersion by supercritical fluid (SEDS); Lysozyme; Nanoparticle; Pulmonary delivery;
Citations & Related Records
연도 인용수 순위
  • Reference
1 M.A. Winter, B.L. Knutson, P.G. Debenedetti and H.G. Sparks, Precipitation of protein in supercritical carbon dioxide, J. Pharm. Sci., 85, 586-594 (1996)   DOI   ScienceOn
2 R. Subramaniam, R.A. Rajewski and K. Snavely, Pharmaceutical processing with supercritical carbon Dioxide, J. Pharm. Sci., 86(8), 885-890 (1997)   DOI   ScienceOn
3 S. Yeo, G. Lim, P.G. Debenedetti, and H. Bernstein, Formation of microparticulate protein powders using a supercritical fluid antisolvent, Biotechnol. Bioeng, 41, 341-346 (1993)   DOI
4 M.H. Hanna, P. York, Method and apparatus for the formulation of particles using a supercritical fluid, European Patent, Patent No 706421B1 (1998)
5 K. During, P. Porsch, A. Mahn, O. Brinkmann, W. Gieffers, The non-enzymatic microbicidal activity of lysozyme, FEBS Lett, 449, 93-100 (1999)   DOI   ScienceOn
6 P.L. Smith, Peptide delivery via the pulmoruny route: A valid approach for local systemic delivery, J. Controlled Rel., 46, 99-106 (1997)   DOI   ScienceOn
7 A.J. Hickey, D.C Thompson, Physiology of the airways: In A.J. Hickey, editor. Pharmaceutical inhalation Aerosol Technology, Marcel Dekker, New York, pp. 61-82 (1992)
8 R.F. Service, Drug delivery takes a deep breath, Science, 277, 1199-1200 (1997)   DOI   ScienceOn
9 Gonda, Targeting by deposition: In AJ Hickey, editor, Pharmaceutical Inhalation Aerosol Technology, Marcel Dekker, New York, pp. 1-27 (1992)
10 H.R. Ibrahim, On the novel catalytically-independent antimicrobial function of hen egg-white lysozyme, Nahrung, 42, 187-193 (1998)   DOI   ScienceOn
11 J. Jung, M. Perrut, Particle Design using Supercritical Fluids: Literature and Patent Survey, J. Supercrit. Fluids, 20, 179-219 (2001)   DOI   ScienceOn
12 M. Jackson, H.H. Mantsch, Beware of protein in DMSO, Biochim. Biophys. Acta., 1078, 231-235 (1991)   DOI   ScienceOn
13 D.A. Cowan, Protein stability at high temperatures, Essays Biochem., 29, 193-207 (1995)
14 D.P. Nesta, J.S. Elliott, and J.P. Warr, Supercritical fluid precipitation of recombinant human immunoglobulin from aqueous solution, Biotechnol. Bioeng., 67, 457-464 (2000)   DOI   ScienceOn
15 H.K. Chan, A. Clark, I. Gonda, M. Mumenthaler, and C. Hsu, Spray dried powders and powder blends of recombinant human deoxyribonuclease for aerosol delivery, Pharm. Res., 14, 431-437 (1997)   DOI   ScienceOn
16 R.T. Bustani, H.K. Chan, F. Dehghani and N.R. Foster, Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide, Pharm. Res., 17, 1360-1366 (2000)   DOI   ScienceOn
17 M. Hanna, P. York, Method and apparatus for the formation of particles, Patent WO 95/01221 (1994)
18 D. Verhanune, J. Storck, L. Racchelli and A. Lauwers, Lysozyme(N-acetylmuramyl $\beta$(1-4) glycanohydrolase EC 3.2.1.17), Int. J. Pharm., 2, 168-171 (1988)
19 R. Thiering, F. Dehghani, A. Dillow, and N.R. Foster, The influence of operating condition on the dense gas precipitation of model proteins, J. Chem. Techol. Biotechnol., 75, 12-24 (2000)
20 M.B. King, A. Mubarak, J.D. Kim, and T.R. Bott, The mutual solubilities of water with supercritical and liquid carbon dioxide, J. Supercrit. Fluids, 5, 296-302 (1992)   DOI
21 E. Reverchon, A. Di Trolio, and S. Pace, Supercritical antisolvent precipitation of nanoparticles of superconductor precursors, Ind. Eng. Chem. Res., 37, 952-958 (1998)   DOI   ScienceOn